Famotidine 20 mg Tablet

Adult dose

1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, bleeding ulcers), gastroesophageal reflux disease, Zollinger-Ellison syndrome: Administer 20 mg of famotidine orally twice a day (after breakfast, after dinner, or at bedtime) or 40 mg once a day (at bedtime). In cases of upper gastrointestinal bleeding, treatment usually begins with injections and switches to oral administration when possible.

This medication should not be used in patients with a history of allergy to its components or similar drugs. This drug contains lactose, so it should not be administered to patients with lactose intolerance or certain genetic disorders. Patients with a history of drug allergies should use this medication cautiously. Patients with poor renal function may have elevated concentrations of this drug in the body, thus dosage should be reduced or the dosing interval extended. Patients with heart disease should be cautious as this medication may affect the heart. Patients with impaired liver function should be careful as symptoms may worsen. Elderly patients should use this drug carefully as they may have decreased renal function. This drug may rarely cause serious allergic reactions, blood disorders, skin disorders, liver dysfunction, muscle damage, cardiac rhythm abnormalities, kidney problems, or pneumonia. If any of these symptoms occur, discontinue the medication immediately and seek medical attention. Also, while this medication dissolves in the mouth, it must be swallowed with saliva or water as it is not absorbed in the mouth. It is important to have regular blood tests and liver and kidney function testing to check for abnormalities. When used with certain specific antifungals or anticancer agents, the efficacy of the drugs may decrease, so consult a doctor. Women who are pregnant or may become pregnant should only use this medication when the benefits are deemed greater than the risks. It is recommended that breastfeeding women discontinue breastfeeding as this medication may pass into breast milk. Safety in children has not been sufficiently established, so caution is required for use in this population. While taking this medication, symptoms of gastric cancer may be masked, so ensure malignancy is ruled out before use.

Serious side effects

Shock, hypersensitivity (anaphylaxis, difficulty breathing, general flushing, angioedema <facial swelling, pharyngeal edema, etc.>, urticaria), pancytopenia, agranulocytosis, aplastic anemia, hemolytic anemia, thrombocytopenia (initial symptoms include general malaise, weakness, subcutaneous and mucosal hemorrhage, fever, etc.), Stevens-Johnson syndrome (toxic epidermal necrolysis), liver dysfunction, jaundice, rhabdomyolysis (hyperkalemia, myoglobinuria,

Mild side effects

• Rash
• urticaria (erythema)
• facial swelling
• leukopenia
• eosinophilia
• constipation
• diarrhea
• dry mouth
• nausea
• vomiting

This medication should be stored in a tightly closed container at room temperature between 1°C and 30°C. This will help maintain the drug's efficacy and prevent degradation.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle